Thursday, July 13, 2017

The Link Between Sleep and Alzheimer’s

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition

Summary: A new study published in brain reveals that just one night of sleep disruption causes an increase in amyloid beta in the brains of healthy, middle aged people. A full week of sleep disturbances leads to a build up of Tau, another protein associated with Alzheimer’s and other neurodegenerative diseases. The study sheds light on why poor sleep has previously been associated with the development of Alzheimer’s and other dementias.
Source: WUSTL.
Poor sleep leads to increase in Alzheimer’s proteins associated with cognitive decline.
A good night’s sleep refreshes body and mind, but a poor night’s sleep can do just the opposite. A study from Washington University School of Medicine in St. Louis, Radboud University Medical Centre in the Netherlands, and Stanford University has shown that disrupting just one night of sleep in healthy, middle-aged adults causes an increase in amyloid beta, a brain protein associated with Alzheimer’s disease. And a week of tossing and turning leads to an increase in another brain protein, tau, which has been linked to brain damage in Alzheimer’s and other neurological diseases.
“We showed that poor sleep is associated with higher levels of two Alzheimer’s-associated proteins,” said David M. Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor, head of the Department of Neurology and the study’s senior author. “We think that perhaps chronic poor sleep during middle age may increase the risk of Alzheimer’s later in life.”
These findings, published July 10 in the journal Brain, may help explain why poor sleep has been associated with the development of dementias such as Alzheimer’s.
More than 5 million Americans are living with Alzheimer’s disease, which is characterized by gradual memory loss and cognitive decline. The brains of people with Alzheimer’s are dotted with plaques of amyloid beta protein and tangles of tau protein, which together cause brain tissue to atrophy and die. There are no therapies that have been proven to prevent, slow or reverse the course of the disease.
Previous studies by Holtzman, co-first author Yo-El Ju, MD, an assistant professor of neurology, and others have shown that poor sleep increases the risk of cognitive problems. People with sleep apnea, for example, a condition in which people repeatedly stop breathing at night, are at risk for developing mild cognitive impairment an average of 10 years earlier than people without the sleep disorder. Mild cognitive impairment is an early warning sign for Alzheimer’s disease.
But it wasn’t clear how poor sleep damages the brain. To find out, the researchers — Holtzman; Ju; co-first author and graduate student Sharon Ooms of Radboud; Jurgen Claassen, MD, PhD, of Radboud; Emmanuel Mignot, MD, PhD, of Stanford; and colleagues — studied 17 healthy adults ages 35 to 65 with no sleep problems or cognitive impairments. Each participant wore an activity monitor on the wrist for up to two weeks that measured how much time they spent sleeping each night.
After five or more successive nights of wearing the monitor, each participant came to the School of Medicine to spend a night in a specially designed sleep room. The room is dark, soundproof, climate-controlled and just big enough for one; a perfect place for sleeping, even as the participants wore headphones over the ears and electrodes on the scalp to monitor brain waves.
Half the participants were randomly assigned to have their sleep disrupted during the night they spent in the sleep room. Every time their brain signals settled into the slow-wave pattern characteristic of deep, dreamless sleep, the researchers sent a series of beeps through the headphones, gradually getting louder, until the participants’ slow-wave patterns dissipated and they entered shallower sleep.
The next morning, the participants who had been beeped out of slow-wave sleep reported feeling tired and unrefreshed, even though they had slept just as long as usual and rarely recalled being awakened during the night. Each underwent a spinal tap so the researchers could measure the levels of amyloid beta and tau in the fluid surrounding the brain and spinal cord.
A month or more later, the process was repeated, except that those who had their sleep disrupted the first time were allowed to sleep through the night undisturbed, and those who had slept uninterrupted the first time were disturbed by beeps when they began to enter slow-wave sleep.
The researchers compared each participant’s amyloid beta and tau levels after the disrupted night to the levels after the uninterrupted night, and found a 10 percent increase in amyloid beta levels after a single night of interrupted sleep, but no corresponding increase in tau levels. However, participants whose activity monitors showed they had slept poorly at home for the week before the spinal tap showed a spike in levels of tau.
“We were not surprised to find that tau levels didn’t budge after just one night of disrupted sleep while amyloid levels did, because amyloid levels normally change more quickly than tau levels,” Ju said. “But we could see, when the participants had several bad nights in a row at home, that their tau levels had risen.”
Slow-wave sleep is the deep sleep that people need to wake up feeling rested. Sleep apnea disrupts slow-wave sleep, so people with the disorder often wake up feeling unrefreshed, even after a full eight hours of shut-eye.
Slow-wave sleep is also the time when neurons rest and the brain clears away the molecular byproducts of mental activity that accumulate during the day, when the brain is busily thinking and working.
Ju thinks it is unlikely that a single night or even a week of poor sleep, miserable though it may be, has much effect on overall risk of developing Alzheimer’s disease. Amyloid beta and tau levels probably go back down the next time the person has a good night’s sleep, she said.

Research from Washington University School of Medicine in St. Louis, Radboud University Medical Centre in the Netherlands, and Stanford University shows that disrupting just one night of sleep in healthy, middle-aged adults causes an increase in a brain protein associated with Alzheimer’s disease. Further, a week of poor sleep leads to an increase in another brain protein that has been linked to brain damage in Alzheimer’s and other neurological diseases. Shown are brain waves during slow-wave sleep, measured as a study participant slept. NeuroscienceNews.com image is credited to Yo-El Ju.
“The main concern is people who have chronic sleep problems,” Ju said. “I think that may lead to chronically elevated amyloid levels, which animal studies have shown lead to increased risk of amyloid plaques and Alzheimer’s.”
Ju emphasized that her study was not designed to determine whether sleeping more or sleeping better reduce risk of Alzheimer’s but, she said, neither can hurt.
“Many, many Americans are chronically sleep-deprived, and it negatively affects their health in many ways,” Ju said. “At this point, we can’t say whether improving sleep will reduce your risk of developing Alzheimer’s. All we can really say is that bad sleep increases levels of some proteins that are associated with Alzheimer’s disease. But a good night’s sleep is something you want to be striving for anyway.”
ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE
Funding: Funding provided by National Institutes of Health, J.P.B Foundation, Alzheimer Nederland, Washington University Institute of Clinical and Translational Sciences, National Center for Advancing Translational Sciences.
Source: Judy Martin Finch – WUSTL
Image Source: NeuroscienceNews.com image is credited to Yo-El Ju.
Original Research: Full open access research for “Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels” by Yo-El S. Ju, Sharon J. Ooms, Courtney Sutphen, Shannon L. Macauley, Margaret A. Zangrilli, Gina Jerome, Anne M. Fagan, Emmanuel Mignot, John M. Zempel, Jurgen A.H.R. Claassen, and David M. Holtzman in Brain. Published online July 10 2017 

Tuesday, July 11, 2017

Drug Restores Cells and Memories in Alzheimer’s: Mouse Study

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition


Summary: A new drug has proven effective at restoring memories and neural connections in mouse models of Alzheimer’s disease. The new drug was originally developed as a treatment for Schizophrenia. While the drug does not destroy amyloid plaques associated with Alzheimer’s, it does allow the plaques to co-exist with neurons.
Source: Yale.
A new drug can restore memories and connections between brain cells in mice with a model of Alzheimer’s disease, a new Yale-led study suggests.
“The drug completely erased evidence of Alzheimer’s synapse damage and memory loss in mouse models of the disease,” said Stephen Strittmatter, the Vincent Coates Professor of Neurology and senior author of the study appearing July 5 in the journal Cell Reports.
Researchers such as Strittmatter have made significant inroads into understanding the biology of Alzheimer’s disease, but identifying effective and safe treatments has been difficult. It is known that amyloid-beta peptides, the hallmark of Alzheimer’s, couple with prion protein at the surface of brain cells and transmit damaging instructions to the interior of the cell. Yale researchers had previously identified a protein on the cell membrane — metabotropic glutamate receptor 5 or mGluR5 — as the gateway that helps transmit damage from the coupling.
Previous attempts had been made to target mGluR5, but most drugs also disrupt signaling of glutamate, the most common neurotransmitter in the human brain. The new compound, Silent Allosteric Modulation or SAM (BMS 984923), was created by Bristol Myers Squibb as part of its effort to treat schizophrenia. The drug does not restrict neurotransmitter signaling in culture tissue or living mice, the study found. After four weeks of treatment, memory and synapses linking brain cells had been restored in mice with a model of Alzheimer’s.
“The drug does not destroy plaques associated with Alzheimer’s, but allows them to co-exist with neurons,” Strittmatter said.
Image shows cortical tissue.
Cortical tissue with plaques stained in blue, and astrocytes responding to drug treatment in red. NeuroscienceNews.com image is credited to the researchers.
Yale researchers say the next step is to prepare for preliminary trials of the drug’s effects on humans.
Primary funding for the research comes from the National Institutes of Health.
ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE
Yale’s Laura T. Haas is lead author of the study. Researchers from Bristol-Myers Squibb Research and Development also contributed to the paper.
Source: Bill Hathaway – Yale

Sunday, July 9, 2017

Sleep Problems May Be An Early Sign of Alzheimer’s

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


Summary: A new study links sleep problems with increased biomarkers for Alzheimer’s disease. Researchers discovered those who report low sleep quality, daytime sleepiness and other sleep problems had elevated levels of Alzheimer’s related biomarkers in their spinal fluid than those who reported no sleep problems. However, no abnormalities were found in the spinal fluid of people with obstructive sleep apnea.
Source: AAN.
Poor sleep may be a sign that people who are otherwise healthy may be more at risk of developing Alzheimer’s disease later in life than people who do not have sleep problems, according to a study published in the July 6, 2017, online issue of Neurology. Researchers have found a link between sleep disturbances and biological markers for Alzheimer’s disease found in the spinal fluid.
“Previous evidence has shown that sleep may influence the development or progression of Alzheimer’s disease in various ways,” said study author Barbara B. Bendlin, PhD, of the University of Wisconsin-Madison. “For example, disrupted sleep or lack of sleep may lead to amyloid plaque buildup because the brain’s clearance system kicks into action during sleep. Our study looked not only for amyloid but for other biological markers in the spinal fluid as well.”
Amyloid is a protein that can fold and form into plaques. Tau is a protein that forms into tangles. These plaques and tangles are found in the brains of people with Alzheimer’s disease.
For the study, researchers recruited 101 people with an average age of 63 who had normal thinking and memory skills but who were considered at risk of developing Alzheimer’s, either having a parent with the disease or being a carrier of a gene that increases the risk for Alzheimer’s disease called apolipoprotein E or APOE. Participants were surveyed about sleep quality. They also provided spinal fluid samples that were tested for biological markers of Alzheimer’s disease.
Researchers found that people who reported worse sleep quality, more sleep problems and daytime sleepiness had more biological markers for Alzheimer’s disease in their spinal fluid than people who did not have sleep problems. Those biological markers included signs of amyloid, tau and brain cell damage and inflammation.
“It’s important to identify modifiable risk factors for Alzheimer’s given that estimates suggest that delaying the onset of Alzheimer’s disease in people by a mere five years could reduce the number of cases we see in the next 30 years by 6.7 million and save $367 billion in health care spending,” said Bendlin.
While some of these relationships were strong when looking at everyone as a group, not everyone with sleep problems has abnormalities in their spinal fluid. For example, there was no link between biological markers in the spinal fluid and obstructive sleep apnea.
The results remained the same when researchers adjusted for other factors such as use of medications for sleep problems, amount of education, depression symptoms or body mass index.
an alarm clock
While some of these relationships were strong when looking at everyone as a group, not everyone with sleep problems has abnormalities in their spinal fluid. For example, there was no link between biological markers in the spinal fluid and obstructive sleep apnea. NeuroscienceNews.com image is for illustrative purposes only.
“It’s still unclear if sleep may affect the development of the disease or if the disease affects the quality of sleep,” said Bendlin. “More research is needed to further define the relationship between sleep and these biomarkers.”
Bendlin added, “There are already many effective ways to improve sleep. It may be possible that early intervention for people at risk of Alzheimer’s disease may prevent or delay the onset of the disease.”
One limitation of the study was that sleep problems were self-reported. Monitoring of sleep patterns by health professionals may be beneficial in future studies.
ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE
Funding: The study was supported by the National Institute on Aging and the National Institutes of Health National Center for Advancing Translational Sciences.
Source: Renee Tessman – AAN
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: The study will appear in Neurology.

CITE THIS NEUROSCIENCENEWS.COM ARTICLE






The Dementia Caregiver's Little Book of Hope [Kindle Edition

Friday, July 7, 2017

Sleep clears Alzheimers

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition


Beta-amyloid (also known as "plaque") is the main suspect behind Alzheimer's. Sleep cleared it TWICE as quickly as normal in the lab. Find out how sleep doubles the clearance of this dangerous Alzheimer's molecule. 



A mouse study suggests that sleep helps restore the brain by flushing out toxins that build up during waking hours. The results point to a potential new role for sleep in health and disease.



Scientists watched dye flow through the glymphatic system, a brain "plumbing" system, of a mouse when it was asleep (left) and then, later, when it was awake (right). More dye flowed into the brain during sleep. Results from this study suggest the brain may flush out toxic molecules associated with neurodegenerative disorders during sleep. Courtesy of Nedergaard Lab, University of Rochester Medical Center.

Scientists and philosophers have long wondered why people sleep and how it affects the brain. Sleep is important for storing memories. It also has a restorative function. Lack of sleep impairs reasoning, problem-solving, and attention to detail, among other effects. However, the mechanisms behind these sleep benefits have been unknown.

Dr. Maiken Nedergaard and her colleagues at the University of Rochester Medical Center recently discovered a system that drains waste products from the brain. Cerebrospinal fluid, a clear liquid surrounding the brain and spinal cord, moves through the brain along a series of channels that surround blood vessels. The system is managed by the brain’s glial cells, and so the researchers called it the glymphatic system.

The scientists also reported that the glymphatic system can help remove a toxic protein called beta-amyloid from brain tissue. Beta-amyloid is renowned for accumulating in the brains of patients with Alzheimer's disease. Other research has shown that brain levels of beta-amyloid decrease during sleep. In their new study, the team tested the idea that sleep might affect beta-amyloid clearance by regulating the glymphatic system. The work was funded by NIH’s National Institute of Neurological Disorders and Stroke (NINDS).

The researchers first injected dye into the cerebrospinal fluid of mice and monitored electrical brain activity as they tracked the dye flow through the animals’ brains. As reported in the October 18, 2013, edition of Science, the dye barely flowed when the mice were awake. In contrast, when the mice were unconscious—asleep or anesthetized—it flowed rapidly.

Changes in the way fluid moves through the brain between conscious and unconscious states may reflect differences in the space available for movement. To test the idea, the team used a method that measures the volume of the space outside brain cells. They found that this “extracellular” volume increased by 60% in the brain’s cortex when the mice were asleep or anesthetized.

The researchers next injected mice with labeled beta-amyloid and measured how long it lasted in their brains when they were asleep and awake. Beta-amyloid disappeared twice as quickly in the brains of mice that were asleep.

Glial cells control flow through the glymphatic system by shrinking and swelling. The hormone noradrenaline, which increases alertness, is known to cause cells to swell. The researchers thus tested whether the hormone might affect the glymphatic system. Treating mice with drugs that block noradrenaline induced a sleep-like state and increased brain fluid flow and extracellular brain volume. This result suggests a molecular connection between the sleep-wake cycle and the brain’s cleaning system.

The study raises the possibility that certain neurological disorders might be prevented or treated by manipulating the glymphatic system. “These findings have significant implications for treating ‘dirty brain’ diseases like Alzheimer’s,” Nedergaard says. “Understanding precisely how and when the brain activates the glymphatic system and clears waste is a critical first step in efforts to potentially modulate this system and make it work more efficiently.”

Wednesday, July 5, 2017

Another reason sunlight is good for those with vascular dementia

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition

University of Southhampton
Sunlight improves vascular health. That's good for your heart. Discover the good things it does for your brain. 




Exposing skin to sunlight may help to reduce blood pressure and thus cut the risk of heart attack, stroke and vascular dementia, a study published in the Journal of Investigative Dermatology suggests.

Vascular dementia is one of the 3 leading causes of dementia. When it appears together with Alzheimer's disease, which it does quite often, it is called "Mixed dementia".

Research carried out at the Universities of Southampton and Edinburgh shows that sunlight alters levels of the small messenger molecule, nitric oxide (NO) in the skin and blood, reducing blood pressure.

Martin Feelisch, Professor of Experimental Medicine and Integrative Biology at the University of Southampton, comments: “(NO) along with its breakdown products, known to be abundant in skin, is involved in the regulation of blood pressure. When exposed to sunlight, small amounts of (NO) are transferred from the skin to the circulation, lowering blood vessel tone; as blood pressure drops, so does the risk of heart attack and stroke.”

Put simply, what's good for the heart is good for the brain. "Heart-health" is about vascular health, which is to say, it is about blood vessels such as arteries and veins. When blood vessels pop or clog, they cause cardiovascular disease  and vascular dementia. Sunlight, by helping to lower blood pressure, should help avoid these problems. 

On the other hand, limiting sunlight exposure is important to prevent skin cancer. Notwithstanding, the authors of the study, including Dr. Richard Weller of the University of Edinburgh, suggest that going too far in minimizing exposure may be disadvantageous. It seems that one should keep a balance. Otherwise, a person who stays away from the sun too much may end up increasing the risk of prevalent conditions related to cardiovascular disease, such as vascular dementia. 

Cardiovascular disease, often associated with high blood pressure, accounts for 30 per cent of deaths globally each year. Blood pressure and cardiovascular disease are known to vary according to season and latitude, with higher levels observed in winter and in countries further from the equator, where ultraviolet radiation from the sun is lower. 

During the study, the skin of 24 healthy individuals was exposed to ultraviolet (UVA) light from tanning lamps for two sessions of 20 minutes each. In one session, the volunteers were exposed to both the UVA rays and the heat of the lamps. In another, the UV rays were blocked so that only the heat of the lamps affected the skin.

The results suggest that UVA exposure dilates blood vessels, significantly lowers blood pressure, and alters NO metabolite levels in the circulation, without changing vitamin D levels. Further experiments indicate that pre-formed stores of NO in the upper skin layers are involved in mediating these effects. The data are consistent with the seasonal variation of blood pressure and cardiovascular risk at temperate latitudes. 

Professor Feelisch adds: “These results are significant to the ongoing debate about potential health benefits of sunlight and the role of Vitamin D in this process. It may be an opportune time to reassess the risks and benefits of sunlight for human health and to take a fresh look at current public health advice. Avoiding excess sunlight exposure is critical to prevent skin cancer, but not being exposed to it at all, out of fear or as a result of a certain lifestyle, could increase the risk of cardiovascular disease. Perhaps with the exception of bone health, the effects of oral vitamin D supplementation have been disappointing. 

“We believe that NO from the skin is an important, so far overlooked contributor to cardiovascular health. In future studies, we intend to test whether the effects hold true in a more chronic setting and identify new nutritional strategies targeted at maximizing the skin’s ability to store NO and deliver it to the circulation more efficiently



Monday, July 3, 2017

Extra virgin olive oil found to prevent Alzheimer’s and protect the brain’s memory function

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter




The Dementia Caregiver's Little Book of Hope [Kindle Edition


Natural News

When people talk about the health benefits of extra-virgin olive oil, it is usually linked to heart health. However, its effects on a different organ have been in the news lately: The brain. 
Researchers from Temple University have discovered that extra-virgin olive oil (EVOO) can not only help protect against memory loss, but it can also alleviate the conditions associated with Alzheimer’s disease. They reached their conclusion following studies involving mice with induced dementia.
The mice were divided into two groups, one of which was given a diet that was enriched with extra-virgin olive oil. The oil was introduced when the mice were just six months old and had not yet begun to display symptoms of Alzheimer’s.
While the two groups of mice did not show any differences in their appearance immediately following their respective diets, the neuron connections in the brains of the mice on the EVOO diet were better preserved at nine and 12 months, and they also showed better learning and memory ability on tests.
Alzheimer’s disease is believed to begin with a reduction in the brain’s autophagy process, which entails the removal of the toxins and intracellular debris that are firm markers of the illness. Olive oil is able to activate this important process and reduce brain inflammation, thereby protecting against Alzheimer’s.
The consumption of olive oil also helps to reduce the formation of harmful brain structures, such as neurofibrillary tangles and amyloid-beta plaques. Previous research has linked the presence of such structures to an individual’s likelihood of developing Alzheimer’s, with neurofibrillary tangles believed to contribute to the poor memory that is often seen in Alzheimer’s patients.
Senior researcher Professor Domenico Pratico of the Lewis Klein School of Medicine remarked: “Thanks to the autophagy activation, memory and synaptic integrity were preserved, and the pathological effects in animals otherwise destined to develop Alzheimer’s disease were significantly reduced.”
Next, the researchers would like to determine if introducing olive oil at a more advanced age can reverse or stop the illness. This is crucial because many people don’t start to suspect dementia until the illness is already present.
With five million Americans currently living with Alzheimer’s and as many as 16 million expected to develop it by 2050, the time to find a solution is now. Dementia is already a leading cause of poor health and disability, and it’s the sixth-leading cause of death in our nation. In addition to its effects on the patients, this heartbreaking illness also places a tremendous burden on family members and caregivers.

Olive oil’s benefits extend beyond preventing dementia

Avoiding dementia is not the only reason to add more olive oil to your diet. A recent study from Copenhagen University Hospital involving 182 men aged 20 to 60 found that those who consumed a quarter cup of olive oil per day had an average reduction in oxidative damage to DNA cells of 13 percent. It has also been linked to a reduction in stroke and heart disease risk, protection against depression, and healthy cholesterol levels.
However, when you’re looking to increase your intake of olive oil, make sure you know what you’re getting as fraud is widespread in the industry. Many of our country’s best-selling brands failed to meet IOC standards in tests due to adulteration, oxidation, or poor quality. Italian extra-virgin olive oil is commonly mixed with inferior olive oils that are cheaper to produce, or even other types of oil entirely. Experts say that real olive oil starts to solidify when refrigerated.
With so many great health benefits and new ones constantly being discovered by researchers, there is no reason not to start consuming more of this healthy oil.
Sources:

Saturday, July 1, 2017

Prevent Dementia- Muscle in on More Memory

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition

HEALTH RESEARCH:

Can muscle strength gains really fight MCI? (MCI is Mild Cognitive Impairment, sometimes nicknamed "pre-Alzheimer's".) Check out this health tip from Australia's "SMART Trial" for seniors. 




Increased muscle strength leads to improved brain function in adults with Mild Cognitive Impairment (MCI), new results from a recent trial led by the University of Sydney has revealed. 

With 135 million people forecast to suffer from dementia in 2050, the study's findings--published in the Journal of American Geriatrics today--have implications for the type and intensity of exercise that is recommended for our growing ageing population. 

Mild Cognitive Impairment defines people who have noticeably reduced cognitive abilities such as reduced memory but are still able to live independently, and is a precursor to Alzheimer's disease. 

Findings from the Study of Mental and Resistance Training (SMART) trial show, for the first time, a positive causal link between muscle adaptations to progressive resistance training and the functioning of the brain among those over 55 with MCI
The trial was conducted in collaboration with the Centre for Healthy Brain Ageing (CHeBA) at University of New South Wales and the University of Adelaide.

"What we found in this follow up study is that the improvement in cognition function was related to their muscle strength gains" said lead author Dr Yorgi Mavros, from the Faculty of Health Sciences, at University of Sydney.

"The stronger people became, the greater the benefit for their brain."

SMART was a randomised, double-blind trial involving 100 community-dwelling adults with MCI, aged between 55 and 86. They were divided into four groups doing either:
  • Resistance exercise and computerised cognitive training;
  • Resistance exercise and a placebo computerised training (watching nature videos);
  • Brain training and a placebo exercise program (seated stretching/calisthenics); or
  • Placebo physical exercise and placebo cognitive training.
Participants doing resistance exercise prescribed weight lifting sessions twice week for six months, working to at least 80 per cent of their peak strength. As they got stronger, the amount of weight they lifted on each machine was increased to maintain the intensity at 80 per cent of their peak strength.

The primary outcomes of a paper published in 2014 found these participants' global cognition improved significantly after the resistance training, as measured by tests including the Alzheimer's disease Assessment Scale-Cognitive scale. The cognitive training and placebo activities did not have this benefit. The benefits persisted even 12 months after the supervised exercise sessions ended.

"The more we can get people doing resistance training like weight lifting, the more likely we are to have a healthier ageing population," said Dr Mavros.

"The key however is to make sure you are doing it frequently, at least twice a week, and at a high intensity so that you are maximising your strength gains. This will give you the maximum benefit for your brain."

These new findings reinforce research from the SMART trial published earlier this year, whereby MRI scans showed an increase in the size of specific areas of the brain among those who took part in the weight training program. These brain changes were linked to the cognitive improvements after weight lifting.

"The next step now is to determine if the increases in muscle strength are also related to increases in brain size that we saw," said senior author Professor Maria Fiatarone Singh, geriatrician at University of Sydney.

"In addition, we want to find the underlying messenger that links muscle strength, brain growth, and cognitive performance, and determine the optimal way to prescribe exercise to maximise these effects."


MORE INFORMATION:
  • The SMART trial was funded by Australia's National Health and Medical Research Council. It was conducted in collaboration with the Centre for Healthy Brain Ageing (CHeBA) at UNSW and the University of Adelaide.
SOURCE:
  • UNIVERSITY OF SYDNEY




Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info